Review highlights the epidemiology and clinical features of non-glaucomatous optic nerve atrophy, suggesting key insights for diagnosis and treatment.
Non-glaucomatous optic nerve atrophy (ONA) is a polyetiological pathological condition characterized by the loss of retinal ganglion cell axons and structural changes in the optic nerve head. ONA is one of the leading causes of irreversible visual impairment and disability across different age groups. This review presents current data on the epidemiology, clinical and demographic characteristics, pathogenesis, classification, diagnosis, treatment, and prognosis of ONA.
No takes yet. Share an insight, caveat, or question.
Шеремет et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: